437 related articles for article (PubMed ID: 19617536)
1. Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion.
Markovic DS; Vinnakota K; Chirasani S; Synowitz M; Raguet H; Stock K; Sliwa M; Lehmann S; Kälin R; van Rooijen N; Holmbeck K; Heppner FL; Kiwit J; Matyash V; Lehnardt S; Kaminska B; Glass R; Kettenmann H
Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12530-5. PubMed ID: 19617536
[TBL] [Abstract][Full Text] [Related]
2. Glioma-derived versican promotes tumor expansion via glioma-associated microglial/macrophages Toll-like receptor 2 signaling.
Hu F; Dzaye O; Hahn A; Yu Y; Scavetta RJ; Dittmar G; Kaczmarek AK; Dunning KR; Ricciardelli C; Rinnenthal JL; Heppner FL; Lehnardt S; Synowitz M; Wolf SA; Kettenmann H
Neuro Oncol; 2015 Feb; 17(2):200-10. PubMed ID: 25452390
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 2 mediates microglia/brain macrophage MT1-MMP expression and glioma expansion.
Vinnakota K; Hu F; Ku MC; Georgieva PB; Szulzewsky F; Pohlmann A; Waiczies S; Waiczies H; Niendorf T; Lehnardt S; Hanisch UK; Synowitz M; Markovic D; Wolf SA; Glass R; Kettenmann H
Neuro Oncol; 2013 Nov; 15(11):1457-68. PubMed ID: 24014382
[TBL] [Abstract][Full Text] [Related]
4. Glioma-associated microglial MMP9 expression is upregulated by TLR2 signaling and sensitive to minocycline.
Hu F; Ku MC; Markovic D; Dzaye O; Lehnardt S; Synowitz M; Wolf SA; Kettenmann H
Int J Cancer; 2014 Dec; 135(11):2569-78. PubMed ID: 24752463
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin suppresses glioma invasion and migration by reducing microglial MT1-MMP expression.
Yongjun Y; Shuyun H; Lei C; Xiangrong C; Zhilin Y; Yiquan K
J Neuroimmunol; 2013 Jul; 260(1-2):1-8. PubMed ID: 23707077
[TBL] [Abstract][Full Text] [Related]
6. Minocycline reduces glioma expansion and invasion by attenuating microglial MT1-MMP expression.
Markovic DS; Vinnakota K; van Rooijen N; Kiwit J; Synowitz M; Glass R; Kettenmann H
Brain Behav Immun; 2011 May; 25(4):624-8. PubMed ID: 21324352
[TBL] [Abstract][Full Text] [Related]
7. Role of PKC-α in NF-κB-MT1-MMP-mediated activation of proMMP-2 by TNF-α in pulmonary artery smooth muscle cells.
Roy S; Chakraborti T; Chowdhury A; Chakraborti S
J Biochem; 2013 Mar; 153(3):289-302. PubMed ID: 23266860
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma.
Guo P; Imanishi Y; Cackowski FC; Jarzynka MJ; Tao HQ; Nishikawa R; Hirose T; Hu B; Cheng SY
Am J Pathol; 2005 Mar; 166(3):877-90. PubMed ID: 15743799
[TBL] [Abstract][Full Text] [Related]
9. Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP.
Kim S; Huang W; Mottillo EP; Sohail A; Ham YA; Conley-Lacomb MK; Kim CJ; Tzivion G; Kim HR; Wang S; Chen YQ; Fridman R
Biochim Biophys Acta; 2010 Nov; 1803(11):1287-97. PubMed ID: 20620173
[TBL] [Abstract][Full Text] [Related]
10. Glial cell line-derived neurotrophic factor increases matrix metallopeptidase 9 and 14 expression in microglia and promotes microglia-mediated glioma progression.
Huang Y; Zhang B; Haneke H; Haage V; Lubas M; Yuan Y; Xia P; Motta E; Nanvuma C; Dzaye O; Hu F; Kettenmann H
J Neurosci Res; 2021 Apr; 99(4):1048-1063. PubMed ID: 33404121
[TBL] [Abstract][Full Text] [Related]
11. Membrane type-1 matrix metalloproteinase potentiates basic fibroblast growth factor-induced corneal neovascularization.
Onguchi T; Han KY; Chang JH; Azar DT
Am J Pathol; 2009 Apr; 174(4):1564-71. PubMed ID: 19264910
[TBL] [Abstract][Full Text] [Related]
12. SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells.
McClung HM; Thomas SL; Osenkowski P; Toth M; Menon P; Raz A; Fridman R; Rempel SA
Neurosci Lett; 2007 May; 419(2):172-7. PubMed ID: 17490812
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas.
Gabrusiewicz K; Ellert-Miklaszewska A; Lipko M; Sielska M; Frankowska M; Kaminska B
PLoS One; 2011; 6(8):e23902. PubMed ID: 21901144
[TBL] [Abstract][Full Text] [Related]
14. Necrosis induction in glioblastoma cells reveals a new "bioswitch" function for the MT1-MMP/G6PT signaling axis in proMMP-2 activation versus cell death decision.
Belkaid A; Fortier S; Cao J; Annabi B
Neoplasia; 2007 Apr; 9(4):332-40. PubMed ID: 17460777
[TBL] [Abstract][Full Text] [Related]
15. A MT1-MMP/NF-kappaB signaling axis as a checkpoint controller of COX-2 expression in CD133+ U87 glioblastoma cells.
Annabi B; Laflamme C; Sina A; Lachambre MP; Béliveau R
J Neuroinflammation; 2009 Mar; 6():8. PubMed ID: 19272160
[TBL] [Abstract][Full Text] [Related]
16. miR-150-5p and miR-133a suppress glioma cell proliferation and migration through targeting membrane-type-1 matrix metalloproteinase.
Sakr M; Takino T; Sabit H; Nakada M; Li Z; Sato H
Gene; 2016 Aug; 587(2):155-62. PubMed ID: 27154818
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
18. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
[TBL] [Abstract][Full Text] [Related]
19. Targeting a single function of the multifunctional matrix metalloprotease MT1-MMP: impact on lymphangiogenesis.
Ingvarsen S; Porse A; Erpicum C; Maertens L; Jürgensen HJ; Madsen DH; Melander MC; Gårdsvoll H; Høyer-Hansen G; Noel A; Holmbeck K; Engelholm LH; Behrendt N
J Biol Chem; 2013 Apr; 288(15):10195-204. PubMed ID: 23413031
[TBL] [Abstract][Full Text] [Related]
20. Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism.
D'Alessio S; Ferrari G; Cinnante K; Scheerer W; Galloway AC; Roses DF; Rozanov DV; Remacle AG; Oh ES; Shiryaev SA; Strongin AY; Pintucci G; Mignatti P
J Biol Chem; 2008 Jan; 283(1):87-99. PubMed ID: 17991754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
